Atlas Trials

ECP for Immune-related Adverse Events After Checkpoint Inhibitor Treatment

Clinical trial NCT05414552 · COMPLETED

Trial details

NCT number
NCT05414552
Sponsor
University of Freiburg
Status
COMPLETED
Study type
OBSERVATIONAL
Immune Related Adverse EventsColitisHepatitisDermatitis
Start date
2021-06-01
Primary completion
2022-12-30
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.